A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 Study to evaluate the effect of DD01 treatment in overweight/obese patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH).